➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Netupitant

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Netupitant?

Netupitant is an investigational drug.

There have been 14 clinical trials for Netupitant. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2021.

The most common disease conditions in clinical trials are Vomiting, Nausea, and Neoplasms. The leading clinical trial sponsors are Helsinn Healthcare SA, Consorzio Oncotech, and PSI CRO AG.

There are one hundred and twenty-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Netupitant
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)Helsinn Healthcare SAPhase 4
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast CancerInstituto Brasileiro de Controle do CancerPhase 2
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly CisplatinHelsinn Healthcare SAPhase 2/Phase 3

See all Netupitant clinical trials

Clinical Trial Summary for Netupitant

Top disease conditions for Netupitant
Top clinical trial sponsors for Netupitant

See all Netupitant clinical trials

US Patents for Netupitant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Netupitant   Get Started Free Crystalline forms of fosnetupitant Helsinn Healthcare SA (Lugano/Pazzallo, CH)   Get Started Free
Netupitant   Get Started Free Cyclohexyl pyridine derivative KISSEI PHARMACEUTICAL CO., LTD. (Matsumoto, Nagano, JP)   Get Started Free
Netupitant   Get Started Free .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA)   Get Started Free
Netupitant   Get Started Free Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM)   Get Started Free
Netupitant   Get Started Free Method for cancer cell reprogramming STC.UNM (Albuquerque, NM)   Get Started Free
Netupitant   Get Started Free Bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use The Trustees of The University of Pennsylvania (Philadelphia, PA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Netupitant

Drugname Country Document Number Estimated Expiration Related US Patent
Netupitant Australia AU2016335060 2035-10-06   Get Started Free
Netupitant Canada CA2996466 2035-10-06   Get Started Free
Netupitant China CN108137626 2035-10-06   Get Started Free
Netupitant European Patent Office EP3359547 2035-10-06   Get Started Free
Netupitant Japan JP2018531249 2035-10-06   Get Started Free
Netupitant South Korea KR20180064453 2035-10-06   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.